Product image of Antitrombina Iii Baxalta (Antithrombin Iii) supplied by GNH India

Antitrombina Iii Baxalta

Active Ingredient:
Antithrombin Iii
Origin:
EU

Antitrombina Iii Baxalta (Antithrombin Iii)

Antithrombin III by Baxalta is a pharmaceutical product used to manage clotting disorders. This intravenous medication supports blood thinning and is essential for patients requiring anticoagulant therapy.

Manufacturer / TM Owner

Baxalta Innovations Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Antithrombin III is primarily used to prevent and treat blood clots in individuals with hereditary antithrombin deficiency. This medication is often administered to patients undergoing surgery or those at risk of thrombotic events. It plays a crucial role in maintaining proper blood flow by inhibiting the formation of clots.

Side Effects

  • Common effects of Antithrombin III may include localized reactions at the injection site, such as redness or swelling. Some individuals might experience mild allergic reactions. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

  • Antithrombin III should be handled with care, ensuring proper storage and administration. Patients with a history of allergic reactions to similar medications should inform their healthcare provider before use. Follow medical guidance for safe and effective use.

Avoid Interactions

  • Antithrombin III may interact with other anticoagulant medications, increasing the risk of bleeding. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always use under medical supervision.

Frequently Asked Questions

Antithrombin III is used to prevent and treat blood clots in individuals with hereditary antithrombin deficiency, often administered to patients undergoing surgery or at risk of thrombotic events.

Antithrombin III is administered intravenously, typically in a clinical setting under the supervision of a healthcare provider.

Common side effects may include localized reactions at the injection site, such as redness or swelling, and mild allergic reactions.

Antithrombin III may interact with other anticoagulant medications, so it is important to inform your healthcare provider about all medications you are taking.

Individuals with a history of allergic reactions to similar medications should inform their healthcare provider before using Antithrombin III.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Antithrombin Iii

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT